Worldquant Millennium Advisors LLC Amgen Inc Transaction History

Worldquant Millennium Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $245,767 - $290,615	1,147 Added 16.44%	8,124 $1.8 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $2.87 Million - $3.5 Million	-12,722 Reduced 64.58%	6,977 $1.69 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $1.9 Million - $2.42 Million	-8,308 Reduced 29.66%	19,699 $5.17 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $7.61 Million - $8.58 Million	-33,897 Reduced 54.76%	28,007 $6.31 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $6.85 Million - $7.63 Million	-29,701 Reduced 32.42%	61,904 $15.1 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $17.4 Million - $19.3 Million	79,561 Added 660.59%	91,605 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $2.4 Million - $2.74 Million	12,044 New	12,044 $2.71 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.